🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial studies how well pazopanib hydrochloride wo...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2012-08-08
Trial ID
NCT01575548
This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-15
Trial ID
NCT00619424
Treatments Being Tested
This randomized phase II trial is studying how well pazopanib hydrochloride...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2006-06
Trial ID
NCT00454571
Treatments Being Tested
The purpose is to determine the safety, effectiveness and best dose to use ...
Status
Completed
Location
City Of Hope
Start Date
2012-02-09
Trial ID
NCT01472081
Treatments Being Tested
This randomized phase II/III trial studies how well pazopanib, when combine...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2014-08-12
Trial ID
NCT02180867
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
This randomized, placebo-controlled, Phase II trial will compare the combin...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2010-01
Trial ID
NCT01027598
This randomized phase II trial studies how well pazopanib hydrochloride wit...
Status
Terminated
Location
Illinois CancerCare-Peoria
Start Date
2018-02-16
Trial ID
NCT03334409
Treatments Being Tested
This phase II trial studies how well pazopanib hydrochloride works in treat...
Status
Completed
Location
University of Colorado Cancer Center - Anschutz Cancer Pavilion
Start Date
2011-01
Trial ID
NCT01247571
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of nab-sirolim...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-04-01
Trial ID
NCT03660930
Treatments Being Tested